Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Bristol Myers Squibb’s new treatment for schizophrenia didn’t provide additional benefits to patients when given on top of ...

Gene therapy developer CRISPR Therapeutics AG (CRSP) is navigating some regulatory and commercial dynamics. Its flagship gene ...

The agreement allows EditCo to integrate Promega's HiBiT, HaloTag, and NanoLuc protein tagging tech with its knock-in gene ...

The field of fruit ripening involves complex interactions among metabolites that are regulated by various genetic factors, ...

It sounds like science fiction—but with CRISPR gene editing and ancient DNA research advancing rapidly, the idea of bringing the Tyrannosaurus rex back to life doesn’t seem so impossible anymore. But ...

De-extinction, once a concept of science fiction, is becoming a reality through advancements in gene editing technologies ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

Learn more about whether Amarin Corporation plc or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Recent IVG breakthroughs bring gene-edited human embryos closer, with CRISPR-Cas9 making heritable gene editing a reality ...